Teva And Alvotech Launch Humira Rival In US
Hoping To Benefit From Interchangeability And High Concentration Despite Late Launch
Teva and Alvotech have finally launched their adalimumab biosimilar, Simlandi, in the US. While arriving many months behind their rivals, the partners are hoping that the product’s combination of a citrate-free, 100mg/ml high concentration and an interchangeability designation will position it for success.
